Evidence for a Telomere-Independent “Clock” Limiting RAS Oncogene-Driven Proliferation of Human Thyroid Epithelial Cells

REFERENCES

• Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M.. 1988. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549–554
   PubMed Web of Science ®Google Scholar
• Bartkova, J., Lukas, J., Strauss, M., and Bartek, J.. 1998. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027–1037
   PubMedGoogle Scholar
• Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E.. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352
   PubMed Web of Science ®Google Scholar
• Bond, J., Haughton, M., Rowson, J., Gire, V., Wynford-Thomas, D., and Wyllie, F.. 1999. Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol. Cell. Biol. 19:3103–3114
   PubMedGoogle Scholar
• Bond, J. A., Wyllie, F. S., and Wynford-Thomas, D.. 1994. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9:1885–1889
   PubMedGoogle Scholar
• Bond, J. A., Ness, G. O., Rowson, J., Ivan, M., White, D., and Wynford-Thomas, D.. 1996. Spontaneous de-differentiation correlates with extended lifespan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression. Int. J. Cancer 67:563–572
   PubMedGoogle Scholar
• Bond, J. A., Wyllie, F. S., Rowson, J., Radulescu, A., and Wynford-Thomas, D.. 1994. In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 9:281–290
   PubMed Web of Science ®Google Scholar
• Bos, J. L., Fearon, E. R., Hamilton, S. R., Verlaan-de Vries, M., van Boom, J. H., van der Eb, A. J., and Vogelstein, B.. 1987. Prevalence of ras gene mutations in human colorectal cancers. Nature 327:293–297
   PubMed Web of Science ®Google Scholar
• Bos, J. L.. 1989. Ras oncogenes in human cancer: a review. Cancer Res. 49:4682–4689
   PubMed Web of Science ®Google Scholar
• Broccoli, D., Young, J. W., and de Lange, T.. 1995. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92:9082–9086
   PubMed Web of Science ®Google Scholar
• Brown, J. P., Wenyi, W., and Sedivy, J. M.. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277:831–834
   PubMed Web of Science ®Google Scholar
• Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., and Sherr, C. J.. 1999. The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583
   PubMed Web of Science ®Google Scholar
• Coppee, F., Depoortere, F., Bartek, J., Ledent, C., Parmentier, M., and Dumont, J. E.. 1998. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Oncogene 17:631–641
   PubMedGoogle Scholar
• Depoortere, F., Van Keymeulen, A., Lukas, J., Costagliola, S., Bartkova, J., Dumont, J. E., Bartek, J., Roger, P. P., and Dremier, S.. 1998. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J. Cell Biol. 140:1427–1439
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., Peacocke, M., and Campisi, J.. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363–9367
   PubMed Web of Science ®Google Scholar
• Durand, B., Fero, M. L., Roberts, J. M., and Raff, M. C.. 1998. p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 8:431–440
   PubMedGoogle Scholar
• Erickson, L. A., Jin, L., Wollan, P. C., Thompson, G. B., van Heerden, J., and Lloyd, R. V.. 1998. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod. Pathol. 11:169–174
   PubMedGoogle Scholar
• Fearon, E. R., and Vogelstein, B.. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759–767
   PubMed Web of Science ®Google Scholar
• Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L. H., Broudy, V., Perlmutter, R. M., Kaushansky, K., and Roberts, J. M.. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733–744
   PubMed Web of Science ®Google Scholar
• Foster, S. A., Wong, D. J., Barrett, M. T., and Galloway, D. A.. 1998. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18:1793–1801
   PubMed Web of Science ®Google Scholar
• Gire, V., and Wynford-Thomas, D.. 1998. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol. Cell. Biol. 18:1611–1621
   PubMedGoogle Scholar
• Gire, V., Marshall, C. J., and Wynford-Thomas, D.. 1999. Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras. Oncogene 18:4819–4832
   PubMedGoogle Scholar
• Hirai, A., Nakamura, S., Noguchi, Y., Yasuda, T., Kitagawa, M., Tatsuno, I., Oeda, T., Tahara, K., Terano, T., Narumiya, S., Kohn, L. D., and Saito, Y.. 1997. Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J. Biol. Chem. 272:13–16
   PubMed Web of Science ®Google Scholar
• Holliday, R.. 1996. Endless quest. Bioessays 18:3–5
   PubMedGoogle Scholar
• Hu, W., Bellone, C. J., and Baldassare, J. J.. 1999. RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity. J. Biol. Chem. 274:3396–3401
   PubMedGoogle Scholar
• Huschtscha, L. I., Noble, J. R., Neumann, A. A., Moy, E. L., Barry, P., Melki, J. R., Clark, S. J., and Reddel, R. R.. 1998. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 58:3508–3512
   PubMedGoogle Scholar
• Ivan, M., Wynford-Thomas, D., and Jones, C. J.. 1996. Abnormalities of the p16INK4a gene in thyroid cancer cell lines. Eur. J. Cancer 32:2369–2370
   Google Scholar
• Jacobs, J., Kieboom, K., Marino, S., de Pinho, R., and van Lohuizen, M.. 1999. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164–168
   PubMed Web of Science ®Google Scholar
• Jones, C. J., Shaw, J. J., Wyllie, F. S., Gaillard, N., Schlumberger, M., and Wynford-Thomas, D.. 1996. High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines. Mol. Cell. Endocrinol. 116:115–119
   PubMedGoogle Scholar
• Jones, C. J., Soley, A., Skinner, J. W., Gupta, J., Haughton, M. F., Wyllie, F. S., Schlumberger, M., Bacchetti, S., and Wynford-Thomas, D.. 1998. Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp. Cell Res. 240:333–339
   PubMedGoogle Scholar
• Kawada, M., Yamagoe, S., Murakami, Y., Suzuki, K., Mizuno, S., and Uehara, Y.. 1997. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15:629–637
   PubMed Web of Science ®Google Scholar
• Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W.. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015
   PubMed Web of Science ®Google Scholar
• Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., and Koff, A.. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721–732
   PubMed Web of Science ®Google Scholar
• Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J.. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84–88
   PubMed Web of Science ®Google Scholar
• Kruk, P. A., Rampino, N. J., and Bohr, V. A.. 1995. DNA damage and repair in telomeres: relation to aging. Proc. Natl. Acad. Sci. USA 92:258–262
   PubMed Web of Science ®Google Scholar
• Lemoine, N. R., Mayall, E. S., Wyllie, F. S., Williams, E. D., Goyns, M., Stringer, B., and Wynford-Thomas, D.. 1989. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159–164
   PubMed Web of Science ®Google Scholar
• Lemoine, N. R., Staddon, S., Bond, J., Wyllie, F. S., Shaw, J. J., and Wynford-Thomas, D.. 1990. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. Oncogene 5:1833–1837
   PubMed Web of Science ®Google Scholar
• Leone, G., DeGregori, J., Sears, R., Jakoi, L., and Nevins, J. R.. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422–426
   PubMed Web of Science ®Google Scholar
• Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., and Lowe, S. W.. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:3008–3019
   PubMed Web of Science ®Google Scholar
• Lloyd, A. C.. 1998. Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev 8:43–48
   PubMedGoogle Scholar
• Lloyd, R. V., Jin, L., Qian, X., and Kulig, E.. 1997. Aberrant p27kip1 expression in endocrine and other tumors. Am. J. Pathol. 150:401–407
   PubMed Web of Science ®Google Scholar
• Lloyd, R. V., Erickson, L. A., Jin, L., Kulig, E., Qian, X., Cheville, J. C., and Scheithauer, B. W.. 1999. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154:313–323
   PubMed Web of Science ®Google Scholar
• Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J.. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503–506
   PubMed Web of Science ®Google Scholar
• Lukas, J., Sorensen, C. S., Lukas, C., Santoni-Rugiu, E., and Bartek, J.. 1999. p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis. Oncogene 18:3930–3935
   PubMedGoogle Scholar
• Mitra, J., Dai, C. Y., Somasundaram, K., El-Deiry, W. S., Satyamoorthy, K., Herlyn, M., and Enders, G. H.. 1999. Induction of p21WAF1/CIP1 and inhibition of Cdk2 mediated by the tumor suppressor p16INK4a. Mol. Cell. Biol. 19:3916–3928
   PubMed Web of Science ®Google Scholar
• Morgenstern, J. P., and Land, H.. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587–3596
   PubMed Web of Science ®Google Scholar
• Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., and Loh, D. Y.. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720
   PubMed Web of Science ®Google Scholar
• Olson, M. F., Paterson, H. F., and Marshall, C. J.. 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394:295–299
   PubMed Web of Science ®Google Scholar
• Onishi, T., and Hruska, K.. 1997. Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology 138:1995–2004
   PubMedGoogle Scholar
• Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M.. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685
   PubMed Web of Science ®Google Scholar
• Palmero, I., Pantoja, C., and Serrano, M.. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125–126
   PubMed Web of Science ®Google Scholar
• Reddel, R.. 1998. A reassessment of the telomere hypothesis of senescence. Bioessays 20:977–984
   PubMedGoogle Scholar
• Reznikoff, C. A., Yeager, T. R., Belair, C. D., Savelieva, E., Puthenveettil, J. A., and Stadler, W. M.. 1996. Elevated p16 at senescence and loss of 16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 56:2886–2890
   PubMed Web of Science ®Google Scholar
• Russo, I., Silver, A. R., Cuthbert, A. P., Griffin, D. K., Trott, D. A., and Newbold, R. F.. 1998. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene 17:3417–3426
   PubMedGoogle Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W.. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602
   PubMed Web of Science ®Google Scholar
• Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., and Clurman, B. E.. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1464–1478
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and Roberts, J. M.. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512
   PubMed Web of Science ®Google Scholar
• Suarez, H. G., du Villard, J. A., Severino, M., Caillou, B., Schlumberger, M., Tubiana, M., Parmentier, C., and Monier, R.. 1990. Presence of mutations of all three ras genes in human thyroid tumours. Oncogene 5:565–570
   PubMed Web of Science ®Google Scholar
• Takuwa, N., and Takuwa, Y.. 1997. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17:5348–5358
   PubMed Web of Science ®Google Scholar
• Tallini, G., Garcia-Rostan, G., Herrero, A., Zelterman, D., Viale, G., Bosari, S., and Carcangiu, M. L.. 1999. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am. J. Surg. Pathol. 23:678–685
   PubMedGoogle Scholar
• Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H., and Zhang, H.. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661–664
   PubMed Web of Science ®Google Scholar
• Vlach, J., Hennecke, S., and Amati, B.. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:5334–5344
   PubMed Web of Science ®Google Scholar
• Wang, S., Wuu, J., Savas, L., Patwardhan, N., and Khan, A.. 1998. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Hum. Pathol. 29:1304–1309
   PubMedGoogle Scholar
• Weber, J. D., Hu, W., Jefcoat, S. C.Jr., Raben, D. M., and Baldassare, J. J.. 1997. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272:32966–32971
   PubMed Web of Science ®Google Scholar
• Wei, S., and Sedivy, J. M.. 1999. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59:1539–1543
   PubMed Web of Science ®Google Scholar
• Williams, D. W., Williams, E. D., and Wynford-Thomas, D.. 1988. Loss of dependence in IGF-1 for proliferation of human thyroid adenoma cells. Br. J. Cancer 57:535–539
   PubMed Web of Science ®Google Scholar
• Wright, W. E., Shay, J. W., and Piatyszek, M. A.. 1995. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23:3794–3795
   PubMed Web of Science ®Google Scholar
• Wyllie, F. S., Jones, C. J., Skinner, J. W., Haughton, M. F., Wallis, C., Wynford-Thomas, D., Faragher, R. G., and Kipling, D.. 2000. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24:16–17
   PubMed Web of Science ®Google Scholar
• Wynford-Thomas, D.. 1999. Cellular senescence and cancer. J. Pathol. 187:100–111
   PubMedGoogle Scholar
• Wynford-Thomas, D.. 1999. Molecular basis of tumour initiation and progression in the thyroid follicular cell: in vitro models Radiation and thyroid cancer. Thomas, G., Karaoglov, A., and Williams, E. D. 225–238 World Scientific, London, United Kingdom
   Google Scholar
• Yeager, T. R., DeVries, S., Jarrard, D. F., Kao, C., Nakada, S. Y., Moon, T. D., Bruskewitz, R., Stadler, W. M., Meisner, L. F., Gilchrist, K. W., Newton, M. A., Waldman, F. M., and Reznikoff, C. A.. 1998. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev. 12:163–174
   PubMedGoogle Scholar
• Zabludoff, S. D., Csete, M., Wagner, R., Yu, X., and Wold, B. J.. 1998. p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis. Cell Growth Differ. 9:1–11
   PubMedGoogle Scholar
• Zhu, J., Woods, D., McMahon, M., and Bishop, J. M.. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997–3007
   PubMed Web of Science ®Google Scholar